Bcr-abl silencing by specific small-interference RNA expression vector as a potential treatment for chronic myeloid leukemia

Iranian Biomedical Journal

Volumn 14, Issue 1-2, 2010, Pages 1-8

  Mahmodabady, Ali Zaree ^a   Javadi, Hamid Reza ^a   Kamali, Mehdi ^a   Najafi, Ali ^a   Hojati, Zahra ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Bcr abl; K562 cell line; SiRNA

Indexed keywords

BCR ABL PROTEIN; GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; MESSENGER RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; IN VITRO STUDY; RNA INTERFERENCE;

APOPTOSIS; CELL SURVIVAL; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, LEUKEMIC; GENE THERAPY; HUMANS; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 79851486229     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Howard K.A., Rahbek, U.L., Liu, X., Damgaard, C.K., Glud, S.Z., Andersen, M., Morten Ø.A., Hovgaard, M.B., Schmitz, A., Nyengaard, R., Besenbacher, F. and Kjems, J. (2006) RNAinterference in vitro and in vivo using a chitosan/siRNA nanoparticle system. Mol. Ther. 14 (4): 476-484.
2. Hannon, G.J. (2002) RNA interference. Nature 418 (6894): 244-251.
3. Hall, A.H., Spesock, A., Serqueeva, Z., Shaw, B.R. and Alexander, K.A. (2006) High potency silencing by single-stranded boranophosphate siRNA. Nucleic Acids Res. 34 (9): 2773-2781.
4. Elbashir, S.M., Lendeckel, W. and Tuschl, T. (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15 (2): 188-200.
5. Song, E., Lee, S.K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P. and Lieberman, J. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9 (3): 347-351.
6. Novina, C.D., Murray, M.F., Dykxhoorn, D.M., Beresferd, P.J., Riess, J., Lee, S.K., Collman, R.G., Lieberman, J., Shankar, P. and Sharp, P.A. (2002) siRNA-directed inhibition of HIV-1 infection. Nat Med. 8 (7): 681-686.
7. Ye, Y., De Leon, J., Yokoyama, N., Naidu, Y. and Camerini, D. (2005) DBR1 siRNA inhibition of HIV- 1 replication. Retrovirology 2: 63.
8. Tong, W.P., Zhou, Y., Wang, X., Yang, F., Wu, K.L., Wu, J. and Zhang, Y. (2008) An accurate quantitative method for screening effective siRNA probes targeting a Hepatitis B virus transcript in single living cells. Biochem. Biophys. Res. Commun. 367 (4): 866-873.
9. Caplen, N.J., Parrish, S., Imani, F., Fire, A. and Morgan, R.A. (2001) Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA 98 (17): 9742-9747.
10. Yang, D., Buchholz, F., Huang, Z., Goga, A., Chen, C.Y., Brodsky, F.M. and Bishop, J.M. (2002) Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 99 (15): 9942-9947.
11. Deininger, M.W.N., Goldman, J.M. and Melo, J.V. (2000) The molecular biology of chronic myeloid leukemia. Blood 96 (10): 3343-3356.
12. Rana, T.M. (2007) Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol. 8 (1): 23-36.
13. Chen, J., Wall, N.R., Kocher, K., Duclos, N., Fabbro, D., Neuberg, D., Griffin, J.D., Shi, Y. and Gilliland, D.G. (2004) Stable expression of small interfering RNA sensitizes TEL-PDGFβR to inhibition with imatinib or rapamycin. J. Clin. Invest. 113(12): 1784-1791.
14. Lugo, T., Pendergast, A.M., Muller, A.J. and Witte, ON. (1990) Tyrosine kinase activity and transformation potency of bcr-abl oncogene produc ts. Science 247 (4964): 1079-1082.
15. Salesse, S. and Verfaillie, C.M. (2002) BCR/ABL: from molecular mechanisms of leukaemia induction to treatment of chronic myelogenous leukaemia. Oncogene 21(56): 8547-8559.
16. Pakakasama, S., Kajanachumpol, S., Kanjanapongkul, S., Sirachainan, N., Meekaewkunchom, A., Ningsanend, V. and Hongeng, S. (2008) Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia. Int. J. Lab. Hematol. 30 (4): 286S-291S.
17. Radich, J.P., Dai, H., Mao, M., Oehler, V., Schelter, J., Druker, B., Sawyers, C., Shah, N., Stock, W., Willman, C., Friend, S. and Linsley, P.S. (2006) Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc. Natl. Acad. Sci. 103 (8):2794-2799.
18. Withey, J.M., Harvey, A.J. and Crompton, M.R. (2006) RNA interference targeting of Bcr-Abl increases chronic myeloid leukemia cell killingby 17-allylamino-17-demethoxygeldanamycin. Leuk. Res. 30 (5): 553-560.
19. Volpe, G., Panuzzo C., Ulisciani, S. and Cilloni, D. (2009) Imatinib resistance in CML. Cancer Lett. 274 (1): 1-9.
20. Wu, J., Meng, F., Kong, L.Y., Peng, Z., Ying, Y., Bornmann, W.G., Darnay, B.G., Lamothe, B., Sun, H., Talpaz, M. and Donato, N.J. (2008) Association between imatinib-resistant BCR-ABL mutationnegative leukemia and persistent activation of LYN kinase. J. Natl. Cancer Inst. 100 (13): 926-939.
21. von Bubnoff, N., Schneller, F., Peschel, C. and Duyster, J. (2002) BCR-ABL gene mutations in relation to clinical resistance of Philadelphiachromosome-positive leukaemia to STI571: a prospective study. Lancet 359 (9305): 458-459.
22. Sawyers, C.L., Hochhaus, A., Feldman, E., Golman, J.M., Miller, C.B., Ottmann, O.G., Schiffer, C.A., Talpaz, M., Guilhot, F., Deininger, M.W., Fischer, T., O'Brien, S.G., Stone, R.M., Gambacorti-Passerini, C.B., Russell, N.H., Reiffers, J.J., Shea, T.C., Chapuis, B., Coutre, S., Tura, S., Morra, E., Larson, R.A., Saven, A., Peschel, C., Gratwohl, A., Mandelli, F., Ben-Am, M., Gathmann, I., Capdeville, R., Paquette, R.L. and Druker, B.J. (2002) Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood 99 (10): 3530-3539.
23. Lozzio, B.B., Lozzio, C.B., Bamberger, E.G. and Feliu, A.S. (1981). A multipotential leukemia cell line (K-562) of human origin. Proc. Soc. Exp. Biol. Med. 166 (4): 546-550.
24. Kafert, S., Luther, S., Boll, I., Wagner, K., Ganser A. and Eder M. (1999). Functional analysis of a single chain chimeric α/β-GM-CSF receptor: importance of a glutamate residue in the transmembrane region. J. Biol. Chem. 274 (46): 33064-33071.
25. + NOD/SCID-repopulating cells. Blood 99 (2): 709-712.
26. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K. and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (6836): 494-498.
27. Menif, S., El Borgi, W., Jeddi, R., Belakhal, R., Elloumi, M., Laatiri, A., Meddeb, B. and Dellagi, K. (2006) RT-PCR use for the diagnostic of chronic myeloid leukaemia. Arch. Inst. Pasteur Tunis. 83 (1-4): 35-39.
28. Salgame, P., Varadhachary, A.S., Primiano, L.L., Fincke, J.E., Muller, S. and Monestier, M. (1997) An ELISA for detection of apoptosis. Nucleic Acids Res. 25 (3): 680-681.
29. Klucher, K.M., Lopez, D.V. and Daley, G.Q. (1998) Secondary mutation maintains the transformed state in BaF3 cells with inducible BCR/ABL expression. Blood 91(10):3927-3934.
30. Holen, T., Amarzguioui, M., Wiiger, M.T., Babaie, E. and Prydz, H. (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res. 30 (8): 1757-1766.
31. Ge, Q, Eisen, H.N. and Chen, J. (2004) Use of siRNAs to prevent and treat influenza virus infection. Virus Res. 102 (1): 37-42.
32. Rapozzi, V. and Xodo, L.E. (2004) Efficient silencing of bcr/abl oncogene by single- and doublestranded siRNAs targeted against b2a2 transcripts. Biochemistry 43 (51): 16134-16141.
33. Scherr, M., Battmer, K., Winkler, T., Heidenreich, O., Ganser, A. and Eder, M. (2003) Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 101(4): 1566-1569.
34. Holen, T., Amarzguioui, M., Wiiger, M.T., Babaie, E. and Prydz, H. (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 30 (8): 1757-1766.
35. Wohlbold, L., van der Kuip, H., Miething, C., Vornlocher, H.P., Knabbe, C., Duyster, J. and Aulitzky, W.E. (2003). Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 102 (6): 2236-2239.
36. Martiat, P., Martiat, P., Lewalle, P., Taj, A.S., Philippe, M., Larondelle, Y., Vaerman, J.L., Wildmann, C., Goldman, J.M. and Michaux, J.L. (1993) Retrovirally transduced antisense sequences stably suppress P210BCR-ABL expression and inhibit the proliferation of BCR/ABL-containing cell lines. Blood 81(2): 502-509.
37. Bartlett, D.W. and Davis M.E. (2006) Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res. 34 (1): 322-333.
38. Brummelkamp, T.R., Bernards, R. and Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (5567): 550-553.